The clinical spectrum of the conditions induced by homozygous mutations of the CYP24A1 gene spans from idiopathic infantile hypercalcemia in children to recurrent nephrolithiasis and/or nephrocalcinosis with hypercalciuria in adulthood [73,74,75]. This evidence concerns the gene CYP24A1 and nephrolithiasis.